Although both NMOSD AQP4 + and relapsing-remitting multiple sclerosis (RRMS) are autoimmune inflammatory diseases, NMOSD AQP4 + is distinguished by a more severe clinical course, with higher symptom intensity and greater residual disability [1]. This evidence concerns the gene AQP4 and relapsing-remitting multiple sclerosis.